Enabling anti-tumor immunity by unleashing ILC2.
作者信息
Mattiola Irene, Diefenbach Andreas
机构信息
Laboratory of Innate Immunity, Department of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12203, Berlin, Germany.
Berlin Institute of Health (BIH), Anna-Louisa-Karsch Strasse 2, 10117, Berlin, Germany.
出版信息
Cell Res. 2020 Jun;30(6):461-462. doi: 10.1038/s41422-020-0330-9.
Abstract
摘要
相似文献
1
Enabling anti-tumor immunity by unleashing ILC2.通过释放2型固有淋巴细胞来激活抗肿瘤免疫。
Cell Res. 2020 Jun;30(6):461-462. doi: 10.1038/s41422-020-0330-9.
2
Immuno-Oncology beyond TILs: Unleashing TILCs.免疫肿瘤学超越 TIL：释放 TILC。
Cancer Cell. 2020 Apr 13;37(4):428-430. doi: 10.1016/j.ccell.2020.03.021.
3
PD-1 expression affects cytokine production by ILC2 and is influenced by peroxisome proliferator-activated receptor-γ.PD-1 的表达会影响 ILC2 细胞因子的产生，而这一过程受过氧化物酶体增殖物激活受体-γ 的影响。
Immun Inflamm Dis. 2020 Mar;8(1):8-23. doi: 10.1002/iid3.279. Epub 2019 Nov 19.
4
IL33 Stimulates Innate Lymphoid Cells to Recruit CD8 T Cells to PDACs.IL33 可刺激固有淋巴细胞募集 CD8 T 细胞至 PDACs。
Cancer Discov. 2020 Apr;10(4):489. doi: 10.1158/2159-8290.CD-RW2020-032. Epub 2020 Feb 28.
5
[Type 2 innate lymphoid cells and chronic rhinosinusitis].[2型固有淋巴细胞与慢性鼻-鼻窦炎]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016 Apr 5;30(7):585-588. doi: 10.13201/j.issn.1001-1781.2016.07.025.
6
Group 2 Innate Lymphoid Cells (ILC2) Suppress Beneficial Type 1 Immune Responses During Pulmonary Cryptococcosis.组 2 先天淋巴细胞（ILC2）在肺部隐球菌病期间抑制有益的 1 型免疫反应。
Front Immunol. 2020 Feb 14;11:209. doi: 10.3389/fimmu.2020.00209. eCollection 2020.
7
Role of Type 2 Innate Lymphoid Cells in Allergic Diseases.2 型固有淋巴细胞在过敏性疾病中的作用。
Curr Allergy Asthma Rep. 2017 Sep 11;17(10):66. doi: 10.1007/s11882-017-0735-9.
8
Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps.慢性鼻-鼻窦炎伴鼻息肉患者体内 2 型固有淋巴细胞升高和激活。
Immun Inflamm Dis. 2017 Sep;5(3):233-243. doi: 10.1002/iid3.161. Epub 2017 Apr 19.
9
Group 2 Innate Lymphoid Cells in Pulmonary Immunity and Tissue Homeostasis.第 2 组先天淋巴细胞在肺部免疫和组织稳态中的作用。
Front Immunol. 2018 Apr 30;9:840. doi: 10.3389/fimmu.2018.00840. eCollection 2018.
10
Group 2 innate lymphoid cells in the regulation of immune responses.组 2 先天淋巴细胞在免疫应答中的调节作用。
Adv Immunol. 2015;125:111-54. doi: 10.1016/bs.ai.2014.09.004. Epub 2014 Dec 2.
引用本文的文献
1
Myeloid‑derived suppressor cells as targets of emerging therapies and nanotherapies (Review).髓源性抑制细胞作为新兴疗法和纳米疗法的靶点（综述）
Med Int (Lond). 2024 Jun 25;4(5):46. doi: 10.3892/mi.2024.170. eCollection 2024 Sep-Oct.
2
Regulation of tumor angiogenesis by the crosstalk between innate immunity and endothelial cells.天然免疫与内皮细胞之间的相互作用对肿瘤血管生成的调控
Front Oncol. 2023 May 10;13:1171794. doi: 10.3389/fonc.2023.1171794. eCollection 2023.
3
Host Immunity and Immunization Strategies for Clostridioides difficile Infection.艰难梭菌感染的宿主免疫与免疫策略。
Clin Microbiol Rev. 2023 Jun 21;36(2):e0015722. doi: 10.1128/cmr.00157-22. Epub 2023 May 10.
4
Superkine IL-2 and IL-33 Armored CAR T Cells Reshape the Tumor Microenvironment and Reduce Growth of Multiple Solid Tumors.超激动型 IL-2 和 IL-33 装甲 CAR T 细胞重塑肿瘤微环境并减少多种实体瘤的生长。
Cancer Immunol Res. 2022 Aug 3;10(8):962-977. doi: 10.1158/2326-6066.CIR-21-0536.
5
The induction of peripheral trained immunity in the pancreas incites anti-tumor activity to control pancreatic cancer progression.外周训练性免疫的诱导可激发抗肿瘤活性，从而控制胰腺癌的进展。
Nat Commun. 2022 Feb 9;13(1):759. doi: 10.1038/s41467-022-28407-4.
6
The tumor microenvironment in pancreatic ductal adenocarcinoma: current perspectives and future directions.胰腺导管腺癌的肿瘤微环境：当前的观点和未来的方向。
Cancer Metastasis Rev. 2021 Sep;40(3):675-689. doi: 10.1007/s10555-021-09988-w.
7
Neural Regulation of Interactions Between Group 2 Innate Lymphoid Cells and Pulmonary Immune Cells.神经调节 2 型固有淋巴细胞与肺部免疫细胞的相互作用。
Front Immunol. 2020 Oct 29;11:576929. doi: 10.3389/fimmu.2020.576929. eCollection 2020.
Zotero 插件